Northern Mine Rescue Competition and fun-filled Miners’ Picnic return to Yellowknife with seven competing teams gearing up for an exciting event
June 03, 2024 13:27 ET
|
Burgundy Diamond Mines
The 2024 NWT/NU Mine Rescue Competition will take place on June 14 and 15 in Yellowknife, NWT, at the local Multiplex arena.
Significant Results From Diamond Drilling at Belltopper, Victoria
June 03, 2024 12:24 ET
|
Novo Resources Corp.
HIGHLIGHTS A six-hole, 2,529 m, diamond drill program has been completed at the Belltopper Gold Project in Victoria.Significant intercepts include: 5.6 m @ 3.14 g/t Au...
Sezzle and Vallarta Supermarkets Partner to Meet Rising Demand for Buy Now, Pay Later Grocery Options
June 03, 2024 09:04 ET
|
Sezzle
Minneapolis, MN, June 03, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // - Sezzle, a leading Buy Now, Pay Later platform, announces the launch of its partnership with...
Opthea To Present at Clinical Trials at the Summit Meeting
June 03, 2024 07:30 ET
|
Opthea Limited
MELBOURNE, Australia and PRINCETON, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel...
Mobilicom CEO Oren Elkayam to Participate in Fireside Chat at the “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, presented by Maxim Group LLC, on June 5, 2024
June 03, 2024 07:10 ET
|
Mobilicom Limited
Shoham, Israel, June 03, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW), a provider of cybersecurity and robust solutions for drones and robotics, today announced its CEO and...
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial
June 02, 2024 20:38 ET
|
Immutep Limited
Phase III collaboration will evaluate efti in combination with KEYTRUDA, MSD’s anti-PD-1 therapy, and standard chemotherapy in first-line non-small cell lung cancer (1L NSCLC)TACTI-004 Phase III trial...
Mesoblast Corporate Presentation at Investor Conference
June 02, 2024 20:23 ET
|
Mesoblast Limited
NEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference. Dr....
Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer Imaging
June 02, 2024 18:43 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, June 03, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has completed the submission of a Biologics License...
Immuron CEO Steven Lydeamore to present at Peak Sky High
May 31, 2024 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief...
Immuron Board Changes
May 31, 2024 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger Aston...